P N Sidharta, A Treiber, J Dingemanse. Clin Pharmacokinet 2015
Times Cited: 26
Times Cited: 26
Johanna Weiss, Dirk Theile, Maximilian Alexander Rüppell, Tobias Speck, Adriana Spalwisz, Walter Emil Haefeli. Eur J Pharmacol 2013
Times Cited: 38
Times Cited: 38
List of shared articles
Times cited
Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities.
Jessica B Badlam, Todd M Bull. Ther Adv Chronic Dis 2017
Jessica B Badlam, Todd M Bull. Ther Adv Chronic Dis 2017
Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided.
Andrea Huppertz, Lars Werntz, Andreas D Meid, Kathrin I Foerster, Jürgen Burhenne, David Czock, Gerd Mikus, Walter E Haefeli. Br J Clin Pharmacol 2018
Andrea Huppertz, Lars Werntz, Andreas D Meid, Kathrin I Foerster, Jürgen Burhenne, David Czock, Gerd Mikus, Walter E Haefeli. Br J Clin Pharmacol 2018
The endothelin receptor antagonist macitentan for the treatment of pulmonary arterial hypertension: A cross-species comparison of its cytochrome P450 induction pattern.
Alexander Treiber, Stephane Delahaye, Swen Seeland, Carmela Gnerre. Pharmacol Res Perspect 2020
Alexander Treiber, Stephane Delahaye, Swen Seeland, Carmela Gnerre. Pharmacol Res Perspect 2020
Effects of Concomitant Administration of PXR Ligand Drugs on the Anticoagulant Effects of Warfarin.
Ayane Mito, Keiichi Hirono, Haruka Ide, Sayaka Ozawa, Fukiko Ichida, Masato Taguchi. Biol Pharm Bull 2022
Ayane Mito, Keiichi Hirono, Haruka Ide, Sayaka Ozawa, Fukiko Ichida, Masato Taguchi. Biol Pharm Bull 2022